Jann Jamieson T, Cunningham Nicole J, Assaf Ryan D, Krysiak Robyn C, Herman David
Health Services, Los Angeles LGBT Center, Los Angeles, California, USA.
Department of Epidemiology, University of California Los Angeles Jonathan and Karin Fielding School of Public Health, Los Angeles, California, USA.
Transgend Health. 2022 Aug 1;7(4):340-347. doi: 10.1089/trgh.2021.0064. eCollection 2022 Aug.
Prior research has found that transgender people are less likely to have access to health care and health insurance than their cisgender peers and are more likely to delay seeking care due to systemic discrimination and stigma. To this end, this study seeks to measure transgender and gender-nonconforming (TGNC) clients' primary care utilization and compare them to their cisgender peers.
Demographic data and self-reported primary care utilization from 14,372 clients attending a community health center in Los Angeles, CA, from 2018 to 2020 were examined. Descriptive statistics and multivariable regression analyses were used to examine correlates of gender identity on primary care utilization metrics-Hepatitis A, Hepatitis B, and Human Papillomavirus (HPV) vaccinations and recent primary care visits.
Of TGNC clients, 38.0% reported being vaccinated for Hepatitis A compared to 49.2% of cisgender clients (<0.01) and 42.6% reported being vaccinated for Hepatitis B compared to 51.6% of cisgender clients (<0.01). TGNC clients had higher odds of engaging with the HPV vaccination series than their cisgender peers (adjusted odds ratio [aOR]=1.28, 95% confidence interval [CI] 1.03-1.59). TGNC clients had higher odds of seeing their primary care provider within the preceding 2 years (aOR=1.72, 95% CI 1.01-2.93) compared to non-TGNC clients.
This study's results found that TGNC clients were more likely to access certain primary care services more often than their cisgender counterparts. Our results support the efficacy of such interventions, such as a health care setting designed to support the health of gender minority people, and see similar, if not greater, primary care engagement in transgender persons compared to their cisgender peers.
先前的研究发现,与顺性别同龄人相比,跨性别者获得医疗保健和医疗保险的机会更少,并且由于系统性歧视和污名化,他们更有可能延迟寻求治疗。为此,本研究旨在衡量跨性别和性别不一致(TGNC)客户的初级保健利用率,并将其与顺性别同龄人进行比较。
对2018年至2020年在加利福尼亚州洛杉矶一家社区健康中心就诊的14372名客户的人口统计学数据和自我报告的初级保健利用率进行了检查。描述性统计和多变量回归分析用于检查性别认同与初级保健利用率指标(甲型肝炎、乙型肝炎和人乳头瘤病毒(HPV)疫苗接种以及最近的初级保健就诊)之间的相关性。
在TGNC客户中,38.0%的人报告接种了甲型肝炎疫苗,而顺性别客户的这一比例为49.2%(<0.01);42.6%的人报告接种了乙型肝炎疫苗,而顺性别客户的这一比例为51.6%(<0.01)。与顺性别同龄人相比,TGNC客户接种HPV疫苗系列的几率更高(调整后的优势比[aOR]=1.28,95%置信区间[CI]1.03-1.59)。与非TGNC客户相比,TGNC客户在过去两年内看初级保健提供者的几率更高(aOR=1.72,95%CI 1.01-2.93)。
本研究结果发现,TGNC客户比顺性别同龄人更有可能更频繁地获得某些初级保健服务。我们的结果支持了此类干预措施的有效性,例如旨在支持性少数群体健康的医疗保健环境,并且与顺性别同龄人相比,跨性别者在初级保健方面的参与度相似,甚至更高。